All News AcouSort AB

Equities

ACOU

SE0009189608

Delayed Nasdaq Stockholm Other stock markets 08:30:05 17/05/2024 pm IST			5-day change	1st Jan Change
10.05 ^SEK	0.00%		-5.63%	-35.37%

02/05	AcouSort AB to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation	CI
29/04	AcouSort AB and GenSensor SAS Enters Collaboration Aiming At Improving Bioreactor Culturing	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AcouSort will exhibit and present at CYTO 2024 – demonstrating the benefits of acoustic sample preparation for flow cytometry applications	02/05	AQ
AcouSort AB to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation	02/05	CI
Communiqué from the annual general meeting of AcouSort AB (publ)	30/04	AQ
AcouSort and Gensensor enter collaboration aiming at improving bioreactor culturing	29/04	AQ
AcouSort AB and GenSensor SAS Enters Collaboration Aiming At Improving Bioreactor Culturing	29/04	CI
AcouWash placed at two potential OEM partners	26/04	AQ
AcouSort Initiates Two AcouWash Lease Collaborations with Potential OEM Partners	26/04	CI
Increased interest for AcouTrap EV isolation for nano flow cytometry applications	04/04	AQ
AcouSort restructures its North American sales operation	03/04	AQ
AcouSort AB Annual report 2023	02/04	AQ
AcouSort AB Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Shareholder interview with AcouSort’s CEO Torsten Freltoft and Commercial Director Agnes Michanek	13/03	AQ
Year end report for AcouSort AB 1 January - 31 December 2023	28/02	AQ
Significant technical progress in the AcouSome project – two novel patent applications filed	31/01	AQ
AcouSort extends collaboration with leading cell therapy company into a third project phase	18/01	AQ
AcouSort attends Advanced Therapies Week to extend its cell therapy network	16/01	AQ
AcouSort : The board of directors resolves to repurchase warrants series 2020/2023	19/12	PU
AcouSort's rights issue is registered - conversion of BTU into shares and warrants	13/12	AQ
FDA approval paves the way for AcouSort's first OEM commercialization within critical care diagnostics	12/12	AQ
AcouSort : rights issue fully subscribed	05/12	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News AcouSort AB

Equities

ACOU

SE0009189608

All News

Filters